Anteris Technologies Global Corp. filed its Form 10-Q for the quarterly period ended September 30, 2026, disclosing a net loss of $26.8 million for the third quarter and $78.5 million for the nine months ended September 30, 2026.

Key Highlights

  • Net loss of $26.8 million for Q3 2026, compared to a net loss of $22.2 million in Q3 2025, according to the filing.
  • Nine-month net loss of $78.5 million for the period ended September 30, 2026, versus $65.2 million in the same period of 2025.
  • Net sales of $519 thousand for Q3 2026, up from $429 thousand in Q3 2025; nine-month net sales were $2.022 million versus $1.603 million.
  • Research and development expense totaled $21.333 million in Q3 2026, compared to $16.810 million in Q3 2025, and $62.159 million for the nine months ended September 30, 2026.
  • Selling, general and administrative expense was $8.901 million in Q3 2026, up from $5.761 million in Q3 2025.
  • Basic and diluted loss per share was $0.28 for Q3 2026, compared to $0.62 in Q3 2025; nine-month loss per share was $0.85 versus $1.80.
  • Shares outstanding as of November 9, 2026 were 97,493,429, the filing reported.

Anteris Technologies Q3 2026 Financial Results: Operating Loss and Expense Growth

Anteris Technologies Global Corp. (NASDAQ:AVR), a Delaware-incorporated company headquartered in Toowong, Queensland, Australia, reported an operating loss of $29.841 million for the three months ended September 30, 2026, according to its quarterly filing. This compares to an operating loss of $22.265 million for the same period in 2025. For the nine months ended September 30, 2026, the company disclosed an operating loss of $84.845 million, against $64.929 million in the prior-year period.

The filing attributed the widening losses in part to increased research and development expenses, which rose to $62.159 million for the nine months ended September 30, 2026, from $49.606 million in the corresponding 2025 period. Selling, general and administrative expenses for the nine-month period were $24.235 million, up from $16.448 million. Cost of products sold for the nine months ended September 30, 2026 was $473 thousand, compared to $478 thousand in the prior-year period.

Other non-operating income, net was $2.600 million for Q3 2026 and $6.742 million for the nine months ended September 30, 2026, the filing stated. Net foreign exchange gains of $160 thousand were recorded for the third quarter, while the nine-month period showed a net foreign exchange loss of $38 thousand. The company reported an income tax benefit of $272 thousand for Q3 2026. The filing noted that Anteris Technologies qualifies as a non-accelerated filer, smaller reporting company, and emerging growth company.

What Was Disclosed

Anteris Technologies Global Corp. filed a Form 10-Q for the quarter ended September 30, 2026, reporting a Q3 net loss of $26.826 million, nine-month net sales of $2.022 million, and 97,493,429 shares outstanding as of November 9, 2026.